Rating History for Iovanace Biotherapeutics (IOVA) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for IOVA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/15/2025 Andrea Newkirk Downgrade Sell
(Buy)		 1.00
(8.00)		 1.87
(5.13)		 174.33% Details